IPF treatment SM001-055 was generally safe and improved lung function, according to top-line data from a Phase 2a trial.

Sam Kirton started his column in November 2021 and writes from his home at Lake Anna, Virginia, where he lives with his wife Susan. His diagnosis at age 59 with idiopathic pulmonary fibrosis in ...

Post-transplant, columnist Sam Kirton avoids negativity at all costs, as it's detrimental to his mental health and overall well-being.

Many factors helped columnist Sam Kirton know when it was time to stop working so he could better attend to his health issues ...

Columnist Charlene Marshall was confused when her latest pulmonary function test results didn't seem to reflect how she was feeling.

Researchers have identified a type of pro-fibrotic immune cell associated with pulmonary fibrosis (PF) in people who develop persistent breathing problems after recovering from COVID-19. The cells’ ...

A Phase 3 clinical trial testing Boehringer Ingelheim’s oral investigational treatment nerandomilast in people with idiopathic pulmonary fibrosis (IPF) has met its primary goal of demonstrating the ...

Charlene Marshall is a fiercely independent 30-something-year-old who can’t sit still. She loves coffee, wine tasting, playing with her dog, and spending time on the beach with her family. She’s a ...